Outlook Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.20-2.831.090.43
Price/Sales ratio
63.229.872.941.49
Earnings per Share (EPS)
$-2.23$-0.95$2.46$6.13

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.39-1.35-1.37-0.84-3.09-0.78-1.48-6.23-3.91-0.93-3.43-0.78
Price/Sales ratio
6.6712.2924.558.6346.193.32N/AN/AN/AN/AN/A3.32
Price/Book Value ratio
-2.11-2.72-14.06-1.07-6.85-2.5118.4871.9129.61-3.8215.29-6.85
Price/Cash Flow ratio
-8.60-2.33-1.60-2.12-4.31-0.83-1.64-6.10-4.56-1.28-4.41-0.83
Price/Free Cash Flow ratio
-6.43-1.76-1.57-2.08-3.98-0.82-1.64-6.10-4.56-1.28-4.41-0.82
Price/Earnings Growth ratio
N/A-0.000.780.010.030.030.010.220.370.03-0.290.03
Dividend Yield
N/AN/AN/A51609.71%1323021.88%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
99.84%99.25%98.90%99.37%99.40%99.70%N/AN/AN/AN/AN/A99.70%
Operating Profit Margin
-136.92%-892.13%-1737.10%-941.36%-824.09%-445.59%N/AN/AN/AN/AN/A-824.09%
Pretax Profit Margin
-146.88%-936.15%-1786.37%-1006.09%-1092.77%-465.67%N/AN/AN/AN/AN/A-1092.77%
Net Profit Margin
-151.73%-908.05%-1789.82%-1019.25%-1493.57%-423.80%N/AN/AN/AN/AN/A-1493.57%
Effective Tax Rate
-3.30%0.38%-0.19%-1.30%10.81%8.99%8.49%-0.00%-0.00%-0.00%-0.00%8.99%
Return on Assets
-39.22%-408.43%-224.96%-187.37%-206.94%-201.48%-178.57%-233.05%-231.53%-182.60%-112.06%-206.94%
Return On Equity
48.01%201.26%1025.52%126.43%221.59%320.55%-1246.95%-1153.96%-756.04%408.53%-348.90%320.55%
Return on Capital Employed
609.56%541.02%-1583.26%448.28%260.73%1150.45%-958.40%-322.10%-716.87%368.12%-137.81%1150.45%
Liquidity Ratios
Current Ratio
N/AN/A0.270.130.100.661.12N/AN/AN/A4.080.10
Quick Ratio
0.400.150.270.130.100.661.123.181.390.663.470.10
Cash ratio
0.240.110.110.110.050.390.782.140.880.503.470.05
Days of Sales Outstanding
173.42300.72N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A-0.18N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
173.42300.53N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
298.81K108.56K56.49K167.93K71.20K34.92K1.57K3.05K6.22K54.30KN/A34.92K
Cash Conversion Cycle
-298.64K-108.26K-56.49K-167.93K-71.20K-34.92KN/AN/AN/AN/AN/A-71.20K
Debt Ratios
Debt Ratio
0.561.710.310.870.800.660.230.510.381.100.740.74
Debt Equity Ratio
-0.69-0.84-1.42-0.58-0.86-1.051.612.551.24-2.462.97-0.86
Long-term Debt to Capitalization
-0.20-0.26-0.75-0.77-0.00-0.000.240.70N/AN/A0.66-0.00
Total Debt to Capitalization
-2.27-5.413.32-1.42-6.2918.420.610.710.551.680.66-6.29
Interest Coverage Ratio
N/AN/A-35.25-6.37-7.61-7.21-20.67N/AN/AN/A-18.30-7.21
Cash Flow to Debt Ratio
-0.35-1.38-6.11-0.85-1.83-2.83-6.96-4.60-5.19-1.20-1.71-1.83
Company Equity Multiplier
-1.22-0.49-4.55-0.67-1.07-1.596.984.953.26-2.233.97-1.07
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.77-5.26-15.26-4.06-10.70-3.96N/AN/AN/AN/AN/A-10.70
Free Cash Flow / Operating Cash Flow Ratio
1.331.321.021.011.081.01111111.01
Cash Flow Coverage Ratio
-0.35-1.38-6.11-0.85-1.83-2.83-6.96-4.60-5.19-1.20-1.71-1.83
Short Term Coverage Ratio
-0.46-1.83-8.74-3.32-1.85-2.84-8.67-60.00-5.19-1.20-1.96K-2.84
Dividend Payout Ratio
N/AN/AN/A-43720.41%-4091831.52%N/AN/AN/AN/AN/AN/A-4091831.52%